Glycom A/S   Report issue

For profit Phase 2
Founded: Horsholm Denmark (2005)
Status: No NME R&D (2005)

Organization Overview

First Clinical Trial
2014
NCT01927900
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Glycom, Inc.